Mechanistic studies on human prolyl hydroxylase domain 2 by Fiorini, G

Biochemistry of the hypoxia-inducible factor hydroxylases by Fiorini, G, Schofield, CJ

Human prolyl hydroxylase domain 2 reacts with O 2 and 2-oxoglutarate to enable formation of inactive Fe(III).2OG.hypoxia-inducible-factor α complexes by Fiorini, G, Marshall, SA, Figg, WD, Myers, WK, Brewitz, L, Schofield, CJ

Newer agents for Helicobacter pylori eradication by Ricci C, Castelli V, Gatta L, Zullo A, Fiorini G, Cassol F, Vaira D

Get full text

Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2 by Figg, WD, Fiorini, G, Chowdhury, R, Nakashima, Y, Tumber, A, McDonough, MA, Schofield, CJ

Antibiotic Resistance and Therapy Outcome in <i>H. pylori</i> Eradication Failure Patients by Saracino I.M., Pavoni M., Zullo A., Fiorini G., Saccomanno L., Lazzarotto T., Cavallo R., Antonelli G., Vaira D.

Get full text

5-substituted pyridine-2,4-dicarboxylate derivatives have potential for selective inhibition of human Jumonji-C domain-containing protein 5 by Brewitz, L, Nakashima, Y, Piasecka, SK, Salah, E, Fletcher, SC, Tumber, A, Corner, TP, Kennedy, TJ, Fiorini, G, Thalhammer, A, Christensen, KE, Coleman, ML, Schofield, CJ

Structure-guided optimisation of N-hydroxythiazole-derived inhibitors of factor inhibiting hypoxia-inducible factor-α by Corner, TP, Teo, RZR, Wu, Y, Salah, E, Nakashima, Y, Fiorini, G, Tumber, A, Brasnett, A, Holt-Martyn, JP, Figg, WD, Zhang, X, Brewitz, L, Schofield, CJ